Revelation Biosciences
Price & Volume
Stats
See more52W Range | $0.96-$47.04 |
Market Cap | $2.2M |
Shares Short | 77,245 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $90.9M |
Diluted EPS | $866.22 |
News
See moreYahoo Finance • 2 months ago
Revelation Biosciences files to sell 13.07M shares of common stock by selling shareholders
Yahoo Finance • 3 months ago
Revolution Beauty directors subscribe for 2 million new shares
Yahoo Finance • 3 months ago
Revolution Beauty raises £15 million through share placement
Yahoo Finance • 3 months ago
Revelation Biosciences Inc (NASDAQ:REVB) Reports Wider-Than-Expected Q2 2025 Loss, Extends Cash Runway to Year-End
About
CEO | Mr. James M. Rolke |
CFO | Mr. Chester Stanley Zygmont III |
Address | 4660 La Jolla Village Drive, San Diego, CA, United States, 92122 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |
